Hasnain Faheem - Insider Non-Derivative Transactions at Mirati Therapeutics, Inc. (MRTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 23, 2024, Hasnain Faheem's relationship to Mirati Therapeutics, Inc. (MRTX) is Director, and currently has 16,035 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MRTX insiders.

Data Source: SEC.
Hasnain Faheem - Insider Non-Derivative Transactions of MRTX Common Stock
Hasnain Faheem - Insider Non-Derivative Transactions at MRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 24, 2024 Disposition -- (Common Stock) 9702 0 0
Jan 24, 2024 Disposition -- (Common Stock) 6333 0 9702
Jan 24, 2024 Disposition -- (Common Stock) 8717 0 16035
Dec 30, 2023 Acquisition -- (Common Stock) 9702 58.75 24752
Aug 12, 2023 P -- (Common Stock) 10791 27.8 10791
Jan 21, 2023 Acquisition -- (Common Stock) 6333 0 15050